arthritis

Oct 04, 2024

Which Key Player Holds the Potential to Corner the Rheumatoid Arthritis Therapeutics Market?

Aug 16, 2022

Novartis’ Canakinumab for NSCLC; Novartis’s Zolgensma Updates; Trodelvy Prospects in New Breast Cancer Use; Novartis Secures European Approval For Pluvicto; Bristol-Myers Squibb’s Abecma Phase III Trials; Trastuzumab Approved for Deruxtecan for HER2-Mutant NSCLC

Mar 25, 2020

Bioelectronic Medicine: Applications and Future Prospects

Feb 19, 2020

Cardiovascular Disease: A major cause of health loss and a global burden

Aug 30, 2018

Outset Medical captures; Wright Medical Group to takeover Cartiva; Y-mAbs Therapeutics prepares for IPO; Biotech boom remunerates analysts

Newsletter/Whitepaper